Mike Lee actually said...

A WRDA has not been authorized since 2007. A new authorization is necessary to continue approved flood control.

Pharmaceutical patents are extremely valuable and it's for good reason that they're valuable.

Opponents of reverse settlements have for several years argued that they're anti-competitive.

Both this recoupment of investment and these profits are jeopardized by lawsuits that are filed by generics.